Experience Matters
Providing expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia.
Welcome to Lucid Health Consulting
With over 30 years of Health Economics, Pricing & Reimbursement, Strategic Market Access and Health Technology Assessment experience, we have helped many organisations navigate the complexities of the Australian regulatory environment and achieve market access.
We have a proven track record of enabling companies and organisations to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.
Let us show you how our strategic approach and team experience can help you achieve market access in Australia.
How we can help your business?
What’s New
Read our articles, find out about our upcoming webinars and speaking engagements for the latest industry insights.
AusMedtech 2022, 24-26 May
AusMedtech 2022, held by AusBiotech, brings together key stakeholders of the Australian and international devices and diagnostics sector to help prepare the industry sector for its changing landscape. This year’s conference will be held at the Melbourne Convention...
2022 ARCS Annual Conference, 23-25 May 2022
If you haven’t already registered for the 2022 ARCS Annual Conference, 23-25 May, now is the time to register with the early bird Conference rate extended to 29 April! This year’s conference theme is “Working together for success” and will be held in person at the...
ISPOR 2022 Virtual Global Conference, 15 – 18 May.
Registration is now open for the ISPOR 2022 In-Person and Virtual Global Conference to be held on May 15-18, 2022, at the Gaylord National Resort and Convention Center in Washington, DC. Join global healthcare leaders, in-person and virtually, as they convene at ISPOR...
What our clients are saying.
Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.